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stratification with histopathology as the reference standard. MATERIALS AND METHODS Twenty-
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Magnetization transfer ratio (MTR) and proton density fat fraction (PDFF) were measured in pancre-
atic tail (PT) and at the resection margin (RM). Histopathologically, pancreatic fibrosis was graded as
mild, moderate, or severe (F1-F3), lipomatosis was graded as 0% to 10%, 11% to 30%, and greater than
30% fat deposition (L1-L3). In addition, MTR and histopathologic fibrosis was assessed in pancreatic
adenocarcinoma. Mann-Whitney U test and Spearman correlation were used. RESULTS Patients with
advanced pancreatic fibrosis (F3) showed a significantly higher MTR compared with the F1 group at the
RM and PT (38 ± 4 vs 32.3 ± 1.6, P = 0.018 and 39.7 ± 5.5 vs 31.2 ± 1.7, P = 0.001). Spearman
correlation coefficient of MTR and fibrosis grade was r = 0.532 (P = 0.011) and 0.554 (P = 0.008),
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lipomatosis grade (RM: r = 0.668 and PT: r = 0.707, P < 0.001). Magnetization transfer ratio was
significantly higher in pancreatic adenocarcinoma compared with pancreatic parenchyma (44 ± 5.5 vs
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Preoperative Evaluation of Pancreatic Fibrosis and Lipomatosis
Correlation of Magnetic Resonance Findings With Histology Using Magnetization
Transfer Imaging and Multigradient Echo Magnetic Resonance Imaging
Khoschy Schawkat, MD,* Dilmurodjon Eshmuminov, MD,† Daniela Lenggenhager, MD,‡
Katharina Endhardt, MD,‡ Bart Vrugt, MD,‡ Andreas Boss, MD, PhD,* Henrik Petrowsky, MD,†
Pierre-Alain Clavien, MD, PhD,† and Caecilia S. Reiner, MD*
Objectives: The purpose of this study was to evaluate the diagnostic performance
of magnetization transfer (MT) imaging and multigradient echo magnetic reso-
nance imaging (MRI) to quantify pancreatic fibrosis and lipomatosis in patients
before pancreatoduodenectomy for postoperative risk stratification with histopa-
thology as the reference standard.
Materials andMethods: Twenty-four patients (age, 68 ± 8 years, 16 males) pro-
spectively underwent quantitative MT imaging using a 2-dimensional gradient
echo sequence with and without MT prepulse and multigradient echo imaging
on a 3 T MRI 1 day before pancreatoduodenectomy due to adenocarcinoma of
the pancreatic head region (n = 20), neuroendocrine tumor (n = 3), or intraductal
papillary mucinous neoplasm (n = 1). Magnetization transfer ratio (MTR) and
proton density fat fraction (PDFF) were measured in pancreatic tail (PT) and at
the resection margin (RM). Histopathologically, pancreatic fibrosis was graded
as mild, moderate, or severe (F1–F3), lipomatosis was graded as 0% to 10%,
11% to 30%, and greater than 30% fat deposition (L1–L3). In addition, MTR
and histopathologic fibrosis was assessed in pancreatic adenocarcinoma. Mann-
Whitney U test and Spearman correlation were used.
Results: Patients with advanced pancreatic fibrosis (F3) showed a significantly
higher MTR compared with the F1 group at the RM and PT (38 ± 4 vs
32.3 ± 1.6, P = 0.018 and 39.7 ± 5.5 vs 31.2 ± 1.7, P = 0.001). Spearman corre-
lation coefficient ofMTR and fibrosis grade was r = 0.532 (P = 0.011) and 0.554
(P = 0.008), respectively. Pancreatic parenchyma with advanced fat deposition
(L2–L3) showed significantly higher PDFF compared with lipomatosis grade
L1 (RM: P = 0.002 and PT: P = 0.001). Proton density fat fraction of pancreatic
parenchyma exhibited a moderate and significant correlation with histo-
pathologic lipomatosis grade (RM: r = 0.668 and PT: r = 0.707,
P < 0.001). Magnetization transfer ratio was significantly higher in pancreatic
adenocarcinoma compared with pancreatic parenchyma (44 ± 5.5 vs 36.0 ± 4.4
and 37.4 ± 5.4, P = 0.004).
Conclusions: Multiparametric MRI of the pancreas including MTR and PDFF
maps may provide quantitative and noninvasive information on pancreatic fibro-
sis and lipomatosis before surgery.
Key Words: magnetization transfer, proton density fat fraction,
pancreatic lipomatosis, pancreatic fibrosis, pancreatic cancer,
pancreatoduodenectomy, postoperative pancreatic fistula
(Invest Radiol 2018;00: 00–00)
T he only potential curative therapy for pancreatic carcinoma at thistime is complete surgical resection, which is still associated
with a risk for postoperative complications.1–3 Development of
postoperative pancreatic fistula is the most relevant complication with
a reported incidence of 10% to 25%2 and often results inmorbidity after
pancreatic resection.4–7 Several factors have been reported to be associ-
ated with an increased rate of postoperative pancreatic fistula (POPF),
such as pancreatic lipomatosis, absence of fibrosis, and small pancre-
atic duct size.4,8–10 Fatty infiltration is thought to increase the softness
of the gland and therefore increases the risk of developing POPF.11,12
Soft pancreas has a high exocrine activity and a poor structure hold-
ing capacity leading to technical difficulties with enteropancreatic
anastomosis. In opposite, hard pancreatic texture caused by in-
creased fibrosis of the pancreatic tissue is associated with decreased
risk of POPF. Fibrotic pancreatic parenchyma has decreased exo-
crine activity,9,11,13 which decreases the risk of proteolytic destruc-
tion of the anastomosis.9 Another favorable aspect of fibrosis relates
to the increased hardness of the pancreatic texture, which better facili-
tates the enteropancreatic anastomosis.
Preoperative evaluation of pancreatic parenchyma texture as an
indicator of postoperative complications would be of interest for risk
stratification of patients and may also influence postoperative patient
care or choice of surgical technique. Some studies have attempted to
predict the risk of POPF with preoperative magnetic resonance imaging
(MRI) by assessing signal characteristics and contrast enhancement of
the pancreatic parenchyma as surrogate for pancreatic fibrosis and
lipomatosis preoperatively.4,12,14,15
Recently, magnetization transfer (MT) MRI has been described
as a method to quantify fibrosis.16 Magnetization transfer describes
the physical process of the exchange of magnetization between free hy-
drogen nuclei and those bound to macromolecules.15,17,18 The MT ef-
fect size depends on the concentrations of these macromolecules, for
example, collagen in an aqueous physiological environment,17 the
higher the concentration of macromolecules, the higher the MT effect
is. Because the free water proton pool is diminished in a fatty environ-
ment, fat deposition in soft tissue environment has a confounding effect
on MT ratio (MTR) values. Measured MTR values are reduced in a
fatty environment.17–20 Previous reports showed MT imaging of the
small bowel with sufficient image quality for identification of fibrotic
scarring in an animal model and in patients with Crohn disease.17,21
Martens et al22 usedMT imaging to assess tumor response after chemo-
radiotherapy in rectal cancer with promising results and showed that
MTR can be used to discriminate postradiation fibrosis from residual
tumor in rectal cancer.23
First applications of MT imaging on the pancreas were reported
by Li et al,24 who evaluated MT for quantification of fibrosis levels in
pancreatic ductal adenocarcinoma in mouse xenograft models.19,24 To
our best knowledge, this study is the first to describe MT imaging of
the pancreas to quantify pancreatic parenchymal fibrosis.
The second component influencing pancreatic texture is pancre-
atic fat deposition, which can be measured with MRI.25 In one previous
study, a moderate relationship of pancreatic fat fraction obtained with a
triple echo gradient echo sequence with histologic findings was found.4
The purpose of this study was to evaluate the diagnostic perfor-
mance of MT imaging and multigradient echo MRI to quantify pancreatic
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fibrosis and lipomatosis in patients before pancreatoduodenectomy
with histopathology as the reference standard.
MATERIALS AND METHODS
Study Population
The local ethics committee approved this prospective study, and
all patients gave written informed consent.
From July 2015 to August 2017, 46 patients were scheduled for
pancreatoduodenectomy of a pancreatic head tumor or periampullary
tumor and considered for study enrolment. Exclusion criteriawere missing
informed consent (8 patients) and metallic implants excluding anMR scan
(1 patient). Thirty-seven consecutive patients underwent preoperative MR
of the pancreas according to the study protocol. Of these 37 patients,
6 patients were excluded because finally no pancreatic resection was per-
formed. Thirty-one patients underwent pancreatoduodenectomy to treat
pancreatic, periampullary, or bile duct tumors, and histopathology
was assessed for the tumors. In 7 patients, the study-relevant MRI se-
quences were acquired incompletely. Thus, the remaining 24 patients
who had a complete preoperative MR examination and underwent
pancreatoduodenectomy were included in this study.
Patients' medical history was assessed (diabetes, prior episodes
of pancreatitis, alcohol and nicotine abuses, hypertension, and obesity).
MRI Scan Acquisition
The MR examinations were performed in a 3 T MRI system
(Skyra; Siemens Healthcare, Erlangen, Germany) with an 18-channel
body array matrix-coil and a built-in 32-channel spine coil. The basic
MRI protocol consisted of the following imaging sequences: T2-
weighted images coronal and axial, T2-weighted images axial fat-
saturated, MR cholangiopancreatography, and noncontrast and dynamic
postcontrast T1-weighted axial fat-saturated images. In addition,MT imag-
ing with a 2-dimensional gradient echo sequence and proton density fat
fraction (PDFF) mapping with multigradient echo Dixon technique were
performed. The off-resonance prepulse of theMT sequence had aGaussian
shape with a frequency offset of 1200 Hz, a maximum effective B1 field
of 6.7 μT, a duration of 9984 microseconds, an effective flip angle of
500 degrees, and a bandwidth of 192 Hz. The MRI parameters for the
MT sequence andmultigradient echo sequence are summarized in Table 1.
Image Analysis
The MTR quantifies the interaction between the unbound water
protons and the macromolecular-bound protons and is defined as
MTR ¼ SI0−SISAT
SI0
where SI0 and SISAT refer to the image intensity without and with the
saturation prepulse, respectively, as earlier described by Pazahr et al.17
Magnetization transfer ratio values were calculated pixelwise and
displayed as MTR maps using an in-house computer script written in
Matlab (R2014a; 8.3.0.532). Magnetization transfer ratio measure-
ments were performed on the MTR maps in Matlab. Proton density
fat fraction maps were generated by the scanner and analyzed using a
DICOM viewing software (Myrian1; Intrasense, Paris, France).
One radiologist (K.S., 5 years of clinical experience) who was
blinded to the histopathologic and clinical findings drew regions of in-
terest (ROIs) on MTR maps and PDFF maps. Regions of interest were
drawn in nontumorous pancreatic tissue distally located to the tumor
avoiding the pancreatic duct and peripancreatic fat with reference of
T2-weighted images. One ROI was drawn at the resection margin
(RM), and one ROI was drawn in the pancreatic tail (PT), where pancre-
atic tissue was best visible on the MTR and PDFF maps (Fig. 1). The
TABLE 1. MRI Parameters of the Magnetization Transfer and
Multigradient Echo Sequence
Magnetization
Transfer
Multigradient
Echo Sequence
Repetition time, ms 25 9
Echo time, ms 2.17 1.05
2.46
3.69
4.92
6.15
7.38
Field of view, cm 35–43 39–45
Matrix 256  208 160  140
Bandwidth, Hz 500 1080
Flip angle, degree 20 4
Slice thickness, mm 5 3.5
FIGURE 1. A 41-year-old male patient with insulinoma in the pancreatic head. T2 haste axial images show normal pancreatic anatomy at the level of the
PT (A) depicting the potential RM (D) without morphologic signs of pancreatic atrophy. Fat fraction measurements using PDFF maps (B and E) show
low level of pancreatic lipomatosis (PT, 12.0%; RM, 5.4%) with correlation to histopathology (L1, ≤10%). Magnetization transfer ratio maps were
evaluated with corresponding ROI at the PT (C) and RM (F) showing higher grade of pancreatic fibrosis (36.0 and 32.2, respectively) correlating to
histopathology (F2, moderate fibrosis).
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ROI in the PTwas chosen, because in a clinical setting MTR and PDFF
would be measured preoperatively in the pancreatic parenchyma and
the future RM could not be reliably identified. Therefore, alternative
measurements could be more easily performed in the future remaining
PT. The RM for each case was identified by the radiologist and pathol-
ogist in consensus by matching the surgical specimen and MRI scans
using anatomical landmarks (eg, pancreatic groove, portal vein, and su-
perior mesenteric vein) for guidance. In cases with adenocarcinoma in
the pancreatic head (14 cases of pancreatic ductal adenocarcinoma
and 1 case of distal bile duct adenocarcinomawith the main tumor mass
in the pancreatic head), an ROI was manually placed in the pancreatic
tumor covering as much as possible of the tumor (avoiding tumor mar-
gins) on the axial MT slice with the greatest tumor diameter.
Magnetization transfer ratio values were determined for the skel-
etal muscle tissue, subcutaneous fat, and the spleen as a reference.
Histopathologic Analysis
The histopathologic features of the pancreatic surgical specimens
were evaluated by 2 experienced pathologists in consensus (B.V., 20 years
of experience; D.L., 4 years of experience). The histologic analysis
consisted of the evaluation of the pancreatic parenchyma at the RM re-
garding fibrosis and lipomatosis, and the evaluation of desmoplastic fi-
brosis in the neoplastic lesion. Hematoxylin and eosin staining and
elastic van Gieson staining were performed to grade the amount of fibro-
sis. Hematoxylin and eosin staining was used to grade the degree of fat
deposition. For pancreatic fibrosis previously described grading criteria
were applied26: F0 = normal pancreatic parenchyma, no fibrotic changes;
F1 =mild fibrosis with thickening of periductal fibrous tissue; F2 =mod-
erate fibrosis with marked sclerosis of interlobular septa and no evidence
of architectural changes; and F3 = severe fibrosis with detection of
architectural destruction. For pancreatic lipomatosis, previously de-
scribed grading criteria12 were adapted as follows: L1 = 0% to 10%
deposition, L2 = 11% to 30%, and L3 = greater than 30%.
Statistical Analysis
Statistical analyses were performed using a commercially avail-
able SPSS software Version 22.0.0.0 (IBM Corporation, Armonk,
NY). Descriptive statistics were performed on all data and are expressed
as mean ± standard deviation (SD). All data were tested for normality
using the Kolmogorov-Smirnoff test. Data were analyzed by using Stu-
dents t test to compareMTR and PDFFmeans for the pancreatic tumor,
RM, and the PT.
Mann-Whitney U test and analysis of variance (ANOVA) were
performed to compareMTR and PDFFmeansmeasured in the different
histologic fibrosis and lipomatosis groups (F0–F3, L1–L3). Spearman
correlation coefficients were obtained for each pair of histologic and
MR parameters. Correlation coefficients were interpreted as follows:
weak, 0.2; moderate, 0.5; and strong, 0.8.27 Statistical significance
was defined as P < 0.05.
RESULTS
Characteristics of the Study Population
Twenty-four patients (mean age, 68 ± 8 years; range, 41–83
years) including 16 men (68 years; range, 41–83 years) and 8 women
(69 years; range, 55–79 years) underwent preoperative MRI and
pancreatoduodenectomy for adenocarcinoma of the pancreatic head
(n = 14), adenocarcinoma of the ampulla vateri (n = 3), duodenal ade-
nocarcinoma (n = 2), adenocarcinoma of the distal bile ducts involving
the pancreatic head (n = 1), neuroendocrine tumor (n = 3), and
intraductal papillary mucinous neoplasm (n = 1). One patient showed
massive parenchymal atrophy disallowing an ROI placement in the pan-
creatic parenchyma on MT and PDFF sequences, but was included for
measuring the MTR in the pancreatic tumor. One patient showed severe
artifacts (breathing motion) in the MT sequence and was excluded from
MTR measurements.
In total, 22 patients were included for the MTR measurements
and 23 patients were included for the PDFF measurements of the
pancreatic parenchyma.
The medical history of the included patients revealed that
6 patients had diabetes mellitus type 2, 2 patients had a prior episode
of pancreatitis, 2 patients declared alcohol abuse, 3 patients with nico-
tine abuse, and 14 patients with hypertension. Neither imaging nor his-
tology correlated with these parameters.
Histopathologic Assessment of Pancreatic Fibrosis
and Lipomatosis
Histopathologic analysis of the pancreatic parenchyma at the
RM revealed 4 patients with F1 fibrosis (18%), 7 patients with F2 fibro-
sis (32%), and 11 patients with F3 fibrosis (50%). None of the patients
had normal (F0) pancreatic parenchyma. Lipomatosis in the pancreatic
parenchyma was graded as L1 in 9 patients (39%), L2 in 11 patients
(48%), and L3 in 3 patients (13%).
Quantitative Evaluation of MTR Values in the
Reference Structures
In the quantitative evaluation of the 2-dimensional MT sequence,
wemeasured highMTR values in reference tissues known to exhibit high
MTR: skeletal muscle tissue (48.5% ± 4.0%; n = 24; the erector spinae
muscle) and the spleen (36.1% ± 3.4%; n = 18). In the subcutaneous
fat, low MTR values were measured (4.0% ± 3.5%; n = 24).
Preoperative MR Assessment of Pancreatic Fibrosis
With Magnetization Transfer
The mean MTR at the RM was 36.0 ± 4.4 (P = 0.004), and the
PT was 37.4 ± 5.4 (P = 0.004) and were significantly lower than the
mean MTR for the pancreatic tumor (44 ± 5.5, ranged from 32.6 to
53.7; n = 15, all histologic F3) (Fig. 2). Magnetization transfer ratio
values at the RM and PT showed moderate correlation with the fibrosis
grade (F1–F3) in the specimens (r = 0.532, P = 0.011 and r = 0.554,
P = 0.008, respectively). Magnetization transfer ratio values for the
F3 group were significantly higher compared with the F1 group at the
RM and PT (38.0 ± 4.0 vs 32.3 ± 1.6, P = 0.018 and 39.7 ± 5.5 vs
31.2 ± 1.7, P = 0.001; Fig. 3). Significantly higher MTR values were
also found in the F3 group versus F1 + F2 group for measurements at
the RM (38.0 ± 4.0 vs 33.9 ± 3.7, P = 0.023) and in the F2 versus F1
group in the PT (37.4 ± 3.7 vs 31.2 ± 1.7, P = 0.014). Analysis of var-
iance showed significant difference for the meanMTRvalues of F1 ver-
sus F3 group at the RM (P = 0.013). Mean MTR values for the fibrosis
groups F1 to F3 are summarized in Table 2.
PreoperativeMR Assessment of Pancreatic Lipomatosis
With Proton Density Fat Fraction
Measured mean and SD PDFF values for the RM and PTwere
10% ± 7.5% and 11.1% ± 8% (n = 23). Measured PDFF values at the
RM and PT showed moderate correlation with the lipomatosis grade
(L1–L3) in the specimens (r = 0.668, P < 0.001 and r = 0.707,
P < 0.001, respectively). Proton density fat fraction values for the L3
group demonstrated significantly higher values compared with the L1
group for the RM and PT (16.2 ± 5.1 versus 4.1 ± 2.8, P = 0.012 and
20.4 ± 6.7 versus 4.8 ± 3.8, P = 0.009). Significantly higher PDFF
values were also found for the RM and PT comparing L2 versus L1
(13.1 ± 7.8 vs 4.1 ± 2.8, P = 0.007; 13.6 ± 7.2 vs 4.8 ± 3.8,
P = 0.005) (Fig. 4). Analysis of variance showed significant difference
for the mean PDFF values of L1 versus L2 group at the RM and PT
(P = 0.009 and P = 0.011, respectively) and for L1 versus L3
(P = 0.017 and P = 0.003, respectively). Mean PDFF values for the
lipomatosis groups L1 to L3 are summarized in Table 2.
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Correlation Between MTR and PDFF
Magnetization transfer ratio values did not show a significant
correlation with PDFF values as measured at the RM and in the PT
(r = −0.038 and r = −0.131, P = 0.867 and P = 0.561, respectively).
No significant correlation was found for the mean MTR values
at the RM and the PT and the lipomatosis grade of the specimens
(r = 0.135, P = 0.548 and r = −0.61, P = 0.788, respectively). Magne-
tization transfer ratio values did not vary significantly between different
lipomatosis groups (P = 0.276–0.971, Table 3).
No significant correlation was found for the mean PDFF values
at the RM and the PT and the fibrosis grade of the specimens
(r = −0.151, P = 0.493 and r = −0.219, P = 0.316, respectively). Proton
density fat fraction values did not vary significantly between different
fibrosis groups (P = 0.463–0.989, Table 3).
Analysis of variance showed no significant difference for the
amount of lipomatosis in the different fibrosis groups and vice versa
(RM: P = 0.844 and P = 0.542, respectively; PT: P = 0.724 and
P = 0.983, respectively).
DISCUSSION
This study found that advanced pancreatic fibrosis and lipomatosis
can be noninvasively quantified with MTR and PDFF MRI. Patients with
advanced pancreatic fibrosis or lipomatosis showed significantly higher
MTR and PDFF obtained by using MT and multigradient echo MRI.
The MR data correlated moderately with histology.
Preoperative quantification of pancreatic fibrosis is of special in-
terest as several studies showed that increased fibrosis of pancreatic tis-
sue is associated with a more secure enteropancreatic anastomosis and
FIGURE 2. A 76-year-old male patient with adenocarcinoma of the pancreatic head. T2 haste axial sequences show a mass in the pancreatic head
(A, asterisk) and PT atrophy (C, arrow). Magnetization transfer ratio maps (B and D) demonstrate high-grade fibrosis of the adenocarcinoma in the
pancreatic head (B, asterisk) withMTR value of 45.4% ± 7.7% corresponding to desmoplastic reaction in histology and fibrotic changes of the pancreatic
parenchyma (D, arrow) with MTR value 39.1% ± 8.2% (P < 0.001).
FIGURE 3. In the upper row, an example of a 83-year-old male patient with a neuroendocrine tumor of the papilla vateri is displayed (A, histopathology;
B, T2w axial slice; and C, MT sequence axial slice) who shows severe fibrosis in histopathology (F3) with higher MTR values (RM, 39.2% ± 12.1%; PT,
36.9% ± 11.7%) compared with a 67-year-old male patient with adenocarcinoma of the pancreatic head (lower row, D–F) who shows mild fibrosis in
histopathology (F1) and lower MTR values (RM, 30% ± 6.3%; PT, 31.2% ± 6.6%). A and D, Elastic van Gieson staining; Scale bar, 1 mm.
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less exocrine function.11,13 Other investigators used the pancreas-to-
muscle signal intensity ratio on fat-suppressed T1-weighted MRI scans
as a marker for pancreatic fibrosis and showed significant correlation
with histology.12 Yoon et al4 also used the pancreas-to-muscle signal in-
tensity ratio to quantify pancreatic fibrosis and showed a moderate rela-
tionship with histologic finding as patients with advanced fibrosis had
significant lower SI ratios than did patients with mild fibrosis. Signal
intensity analysis of pancreatic parenchyma on fat-suppressed T1-
weighted images, however, may be altered in abnormal parenchyma
owing to pancreatic atrophy, fibrosis, edema, or fat deposition, which
can be confounding factors. To overcome this problem, we applied an
MRI technique based on MT principle to measure pancreatic fibrosis.
Physically, MT is a dynamic process that affects spin diffusion between
free water molecules and those bound to macromolecules.19 Thus, MT
MRI generates contrast that is primarily determined by the fraction of
large macromolecules (eg, in fibrosis) or phospholipid and cell mem-
branes within the interrogated tissue.19,28,29 As proof of concept, we
compared MTR in pancreatic adenocarcinomas, known to exhibit
desmoplasia related high-grade fibrosis, with MTR measured in pan-
creatic parenchyma. We found significantly higher MTR in pancreatic
tumor compared with pancreatic parenchyma at the RM and PT. All
pancreatic adenocarcinomas showed high-grade desmoplastic fibrosis
at histology. This finding is in line with previous studies demonstrating
that MT MRI can depict desmoplastic stroma in subcutaneous xeno-
graft mouse tumor models of pancreatic ductal adenocarcinoma and of-
fers the potential of noninvasive quantification of fibrosis levels.19,24
Furthermore, the MTR values of the pancreatic parenchyma followed
the histologic grades of fibrosis with a moderate correlation as well.
TABLE 2. MTR and PDFF Measurements for Different
Histopathological Grades of Fibrosis and Lipomatosis
MTR PDFF
RM PT RM PT
Fibrosis grade
F1 (n = 4) 32.3 ± 1.6 31.2 ± 1.7 12.1 ± 5.1 14.1 ± 4.2
F2 (n = 7) 34.8 ± 4.5 37.4 ± 3.7 9.5 ± 7.9 10.3 ± 6.7
F3 (n = 11) 38.0 ± 4.0 39.7 ± 5.5 9.5 ± 8.4 10.5 ± 9.8
Lipomatosis grade
L1 (n = 9) 35.8 ± 3.4 37.7 ± 4.3 4.1 ± 2.8 4.8 ± 3.8
L2 (n = 11) 35.3 ± 4.8 37.3 ± 6.2 13.1 ± 7.8 13.6 ± 7.2
L3 (n = 3) 38.6 ± 5.4 37.1 ± 0.8 16.2 ± 5.1 20.4 ± 6.7
Data aremean ± standard deviation. For pancreatic lipomatosis: L1= 0%–10%
deposition, L2 = 11%–30%, and L3 = greater than 30%.
MTR indicates magnetization transfer ratio; PDFF, proton density fat fraction;
RM, resectionmargin; PT, pancreatic tail; F1,mild fibrosis; F2,moderate fibrosis;
and F3, severe fibrosis.
FIGURE 4. In the upper row, an example of a 41-year-old male patient with insulinoma is displayed (A, histopathology; B, T2w axial slice; and C, PDFF
sequence axial slice) who shows mild lipomatosis in histopathology (L1 ≤10% fat deposition) with lower PDFF values (RM, 5.4% ± 7.5%;
PT, 12% ± 12.7%) compared with a 67-year-old male patient with adenocarcinoma of the pancreatic head (lower row, D–F) who shows higher grade
of lipomatosis in histopathology (L2, 11%–30% fat deposition) and higher PDFF values (RM, 10.2% ± 15.5%; PT, 18.4% ± 15.8%). A and D,
Hematoxylin and eosin staining; Scale bar, 1 mm.
TABLE 3. Analysis of Variance
Fibrosis Lipomatosis
RM PT RM PT
MTR
F1 vs F2 0.103 0.551 0.609 0.467
F1 vs F3 0.013 0.050 0.589 0.463
F2 vs F3 0.578 0.232 0.989 0.947
PDFF, %
L1 vs L2 0.807 0.874 0.009 0.011
L1 vs L3 0.374 0.886 0.017 0.003
L2 vs L3 0.276 0.971 0.707 0.221
Data are P values. P < 0.05 indicated a significant difference among the
groups. For pancreatic lipomatosis: L1 = 0%–10% deposition, L2 = 11%–30%,
and L3 = greater than 30%.
MTR indicates magnetization transfer ratio; PDFF, proton density fat fraction;
RM, resectionmargin; PT, pancreatic tail; F1, mild fibrosis; F2, moderate fibrosis;
and F3, severe fibrosis.
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The MTR values found for the F1 group at the RM were consistently
significantly lower than for the F3 group. Magnetization transfer ratio
values in the PT were significantly lower in the F1 group than in the
F3 group only in the Mann-Whitney U test (P = 0.018), but not with
analysis of variance (marginal P value of 0.05). This discordance could
be explained by the fact that the histologic fibrosis grades were deter-
mined in the pancreatic parenchyma at the RM and are only estimated
fibrosis levels of the PT.
The observed MTR values for reference tissues such as skeletal
muscle, splenic parenchyma, or subcutaneous fat were in good agree-
ment to previously reported data.17,30,31
Although pancreatic fibrosis has been shown to have a positive
effect on postoperative outcome after pancreatoduodenectomy, a soft
texture related to lipomatosis of the pancreatic parenchyma has been es-
tablished as a risk factor for fistula development.3,9,10,32 Lipomatosis
can be quantified with a chemical shift-based multiecho gradient imag-
ing sequence using the T2* corrected Dixon technique to measure the
PDFF.33 It divides MRI-visible protons bound to fat by all protons in
the parenchyma (bound to fat and water). Fat water separation and
T2* signal decay correction is performed by acquires multiple images
at different echo times. Several studies proved that MRI-PDFF is a ro-
bust and reproducible biomarker for the assessment of nonalcoholic
fatty liver disease (NAFLD).33–37 The research group by Idilman et al25
applied PDFF to determine pancreatic fat deposition in NAFLD. They
report that the mean PDFF values for the pancreatic head, pancreatic
body, and PTwere 4.6% ± 7.1%, 5.7% ± 6.7%, and 6.6% ± 6.1%, re-
spectively, which is in the same range as the L1 lipomatosis group in
our study (mean PDFF values for the RM: 4.1% ± 2.8% and for the
PT: 4.8% ± 3.8%). Kühn et al38 quantified pancreatic fat by PDFF
and report similar mean pancreatic fat content not adjusted for potential
confounders of pancreatic lipomatosis (ie, body mass index) (head,
4.6%; body, 4.9%; tail, 3.9%; being unequally distributed, P < 0.001).
Patel et al39 observed slightly higher PDFFof the pancreas (8.5%) in pa-
tients with NAFLD. In our study, the mean PDFF values of the pancreas
for all included patients were higher (RM: 10% ± 7.5% and PT:
11% ± 8%). This difference may be potentially explained by the fact
that all of our patients had pancreatic head tumors and had a more ad-
vanced age compared with the other studies.25,38,39 Both factors are
known to contribute to a higher degree of fatty atrophy of the
pancreas.40–42 The SDs of the PDFF values in our study were relatively
high, which is probably due to the low spatial resolution of the PDFF
sequence used in this study (Field of view, 39–45 cm; matrix,
160  140) and pancreatic atrophy of this study population resulting
in a slender residual pancreatic parenchyma disallowing the placement
of a large ROI.
In a previous study, Yoon et al4 estimated pancreatic fat fraction
at MRI using T2*-corrected Dixon technique and showed moderate
correlation with histology. Although they used a 3-dimensional triple-
echo gradient-echo sequence, we investigated a multigradient echo se-
quence with 6 echoes. A reduced number of echoes may compromise
the accuracy for R2* estimation and degrade the noise performance
of R2* quantification. However, the optimal number of echoes for
PDFF estimation is controversial. Most studies have evaluated a proto-
type sequence with 6 echoes. Levin et al43 published results showing
that using the 3 or 4 earliest echoes might be of similar or higher accu-
racy. Zand et al44 suggest using 3 to 6 echoes to achieve the highest ac-
curacy for hepatic PDFF estimation. A study by Hernando et al45
propose a minimum number of echoes for robust R2* estimation of 6.
Regarding PDFF estimation of the pancreas, so far no data exist com-
paring the accuracy of 3 or 6 echo techniques. Similar to Yoon et al,4
we found a moderate correlation of PDFF measurements in the pan-
creatic parenchyma and histologic grades of lipomatosis. The
multigradient echo sequence used in this study does not only accurately
quantify pancreatic lipomatosis but would also correct for T2*-decay
pronounced in iron deposition in the pancreas.46Magnetization transfer
in theory would be decreased in the presence of excessive iron overload,
but not in limited iron overload.47 Iron deposition in the pancreas is
mainly described in hemochromatosis or thalassemia major. Because
we did not have any patients with increased risk of pancreatic iron de-
position in our study population, we did not expect any relevant iron de-
position in the pancreas. However, in cases of unknown iron deposition,
the multigradient echo sequence would correct for the T2*-decay.
In this study, we found no differences in PDFF of the pancreas
among patients with different grades of fibrosis. This somehow contra-
dicts the results reported by Yoon et al4 who found significantly higher
fat fractions in patients with advanced fibrosis compared with without
or mild fibrosis. However, our PDFF results are accompanied by histo-
pathologic findings, in which no significant differences in grade of
lipomatosis were detected between the different fibrosis groups.
Fat deposition in soft tissue environment has a confounding ef-
fect on MTR values.17,18,20,48 The MT effect grows with the number
of hydrogen nuclei that switch from a high-mobility environment, such
as in a free water molecule, to a low-mobility environment, such as, for
example, in a hydroxyl group bound to a macromolecule.17 The free
water proton pool is diminished in a fatty environment and therefore
the measured MTR are reduced. Several fat suppression techniques
have been applied to remove the fat component from the MT im-
ages.20,49,50 However, fat-suppression and water- or fat-selective pulses
may cause additional MTeffects and/or alter the steady state of MT se-
quences.48 Because the measured PDFF values in this study correlate
well with histopathologic grading of the pancreatic lipomatosis, it can
be assumed that the applied chemical shift-based multiecho gradient
imaging sequence for fat quantification actually measures the fat depo-
sition in the pancreas. Also theMTRmeasurements in the subcutaneous
fat show good agreement with published datawithMTR close to zero.51
Therefore, the applied 2-dimensional gradient echo sequence for fibro-
sis quantification renders correct quantitative values of MTR in pancre-
atic tissue also in the case of pancreatic lipomatosis. However, it seems
that the lipomatosis of the pancreas in this study population was not
pronounced enough to have a reverse effect on the MTR values.
Because of the small patient number, we were not able to adjust
our results for patient age. Because patient age is beside fatty atrophy of
the pancreas, a risk factor for postoperative pancreatic complications, it
should be tested in future and larger studies whether age and level of
pancreatic fat as measured by PDFF are independent risk factors.
Our study had also certain limitations. The size of the study co-
hort and accordingly the subgroups was rather small. Thus, our results
should be considered preliminary and require confirmation by studies
with larger sample size. Therefore, we performed a retrospective power
analysis for comparison of 2 independent means (Student sample t test)
with continuous values using an alpha of 0.05 and a 2-tailed test. Clin-
ically, a differentiation between high and low to intermediate pancreatic
fibrosis (ie, F3 vs F1 + F2) would be of interest for preoperative risk
stratification. Magnetization transfer ratio in the PT for F3 (n = 11) in
this study was 39.7 ± 5.5 and for F1 + F2 (n = 11) was 34.3 ± 2.7,
resulting in a power of 0.847. The same holds true for the differentiation
of high to intermediate and low grades of lipomatosis in the PT (ie,
L3 + L2 vs L1, respectively). Proton density fat fraction for L3 + L2
(n = 14) in this study was 17 ± 7 and for L1 (n = 9) was 4.8 ± 3.8,
resulting in a power of 0.91.
Because patients with normal pancreas or without suspicion of a
pancreatic tumor do not undergo biopsy or surgery, they could not be
included in this study and are therefore underrepresented. However, it
was still feasible to differentiate pancreatic low-grade from high-grade
fibrosis with MTR. The clinical impact of high-grade fibrosis as mea-
sured with MTR on postoperative patient outcome was not part of this
study, because we first aimed to evaluate the diagnostic performance of
MT imaging. Future studies with a larger patient cohort should focus on
prediction of postoperative patient outcome based on MT measure-
ments of pancreatic fibrosis. Because of the small patient number, we
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were not able to adjust our results for patient age. Because patient age is
beside fatty atrophy of the pancreas a risk factor for postoperative pan-
creatic complications, it should be tested in future and larger studies
whether age and level of pancreatic fat as measured by PDFF are inde-
pendent risk factors. In addition, patients included in the study pre-
sented a variety of pancreatic tumors such as adenocarcinomas as the
largest subgroup as well as intraductal papillary mucinous neoplasm
and neuroendocrine tumors. Different pancreatic cancer etiologies
may have also different effects on the composition of residual pancre-
atic parenchyma. Because we obtained all data with the sameMR scan-
ner, studies including multiple imagers from various vendors are
warranted. Regarding different field strength, MTR values vary only
slightly between 1.5 T and 3.0 T.52 Finally, the current study was per-
formed with ROI-based measurements that encompassed the pancreatic
tissue within one slice for both MRI and histology measurements. This
associated with challenges in coregistration of histology slides to corre-
sponding in vivo MRI measurements. The imprecision associated with
this manual analysis along with the significant difference between MRI
slice thickness (millimeter) and histology tissue slice thickness (mi-
crometer) may have been a key source for the variability between
MRI and histologic measurements.
In conclusion, multiparameteric MRI of the pancreas including
MTR and PDFFmapsmay provide noninvasive information to quantify
pancreatic fibrosis and lipomatosis before pancreatic surgery. Further
studies are needed to investigate whether MTR and PDFF may serve
as an imagingmarker to noninvasively estimate the risk of postoperative
complications associated with pancreatic fibrosis and lipomatosis.
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